Moreover, it was recently demonstrated that the expression of the estrogen receptor (ER) is repressed by miR-206 and that a negative regulatory loop involving miR-221-222 and the ER may confer proliferative advantage and migratory activity to breast cancer cells and promote the transition from ER-positive to ER-negative tumors [47]. This evidence concerns the gene ESR1 and breast carcinoma.